{"entity":{"type":"insider","cik":"0001921783","url":"/insider/0001921783","json_url":"/insider/0001921783.json","name":"RedCo II Master Fund, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":5,"first":"2023-11-22","last":"2026-04-02","span_basis":"filed_date"},"name_variants":[{"name":"RedCo II Master Fund, L.P.","source":"filing","n_filings":5,"first_seen":"2023-11-22","last_seen":"2026-04-02"}],"transactions":[{"id":6150956,"accession":"0001104659-26-039359","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-26-039359","line_url":"/filing/0001104659-26-039359","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5163997.0,"shares_display":"5,163,997","price_per_share":3.279,"price_display":"3.28","price_state":"stated","total_value":16932746.163,"total_display":"16,932,746.16","total_whole":"16,932,746","shares_owned_after":12666731.0,"shares_owned_after_display":"12,666,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-02","scope":"insider","n_lines":2},{"id":6150950,"accession":"0001104659-26-039359","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-039359","line_url":"/filing/0001104659-26-039359","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":331782.0,"shares_display":"331,782","price_per_share":3.799,"price_display":"3.80","price_state":"stated","total_value":1260439.818,"total_display":"1,260,439.82","total_whole":"1,260,440","shares_owned_after":15301237.0,"shares_owned_after_display":"15,301,237","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider","n_lines":2},{"id":6150944,"accession":"0001104659-26-039359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-039359","line_url":"/filing/0001104659-26-039359","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":384636.0,"shares_display":"384,636","price_per_share":3.752,"price_display":"3.75","price_state":"stated","total_value":1443154.272,"total_display":"1,443,154.27","total_whole":"1,443,154","shares_owned_after":15470502.0,"shares_owned_after_display":"15,470,502","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-02","scope":"insider","n_lines":2},{"id":2964386,"accession":"0001104659-24-128575","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-128575","line_url":"/filing/0001104659-24-128575","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares, par value CHF 0.08 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":3.045,"price_display":"3.04","price_state":"stated","total_value":609000.0,"total_display":"609,000.00","total_whole":"609,000","shares_owned_after":15666731.0,"shares_owned_after_display":"15,666,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-13","scope":"insider","n_lines":4},{"id":2306272,"accession":"0001104659-24-126422","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-126422","line_url":"/filing/0001104659-24-126422#line-4","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Green Jeremy; Redmile Group, LLC","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares, par value CHF 0.08 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25352.0,"shares_display":"25,352","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":52478.64,"total_display":"52,478.64","total_whole":"52,479","shares_owned_after":15566731.0,"shares_owned_after_display":"15,566,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-06","scope":"insider"},{"id":2043293,"accession":"0001104659-24-077865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-077865","line_url":"/filing/0001104659-24-077865","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"RedCo II Master Fund, L.P.; Redmile Group, LLC; Green Jeremy","owner_display_name":"RedCo II Master Fund, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares, par value CHF 0.08 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":2.81,"price_display":"2.81","price_state":"stated","total_value":2248000.0,"total_display":"2,248,000.00","total_whole":"2,248,000","shares_owned_after":15669217.0,"shares_owned_after_display":"15,669,217","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider","n_lines":2},{"id":8225144,"accession":"0001104659-23-120752","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-120752","line_url":"/filing/0001104659-23-120752","is_derivative":false,"issuer_cik":"0001425738","issuer_name":"Augmedix, Inc.","issuer_ticker":"AUGX","issuer_name_source":null,"issuer_url":"/issuer/0001425738","owner_cik":null,"owner_name":"Redmile Group, LLC; Green Jeremy; RedCo II Master Fund, L.P.","owner_display_name":"Redmile Group, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":6000000.0,"total_display":"6,000,000.00","total_whole":"6,000,000","shares_owned_after":16404017.0,"shares_owned_after_display":"16,404,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-22","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001771910","name":"ADC Therapeutics SA","url":"/issuer/0001771910","role":"Ten percent owner","n_filings":4,"first_seen":"2024-07-03","last_seen":"2026-04-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001769804","name":"Augmedix, Inc.","url":"/issuer/0001769804","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2023-11-22","last_seen":"2023-11-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001921783","retrieved_at":"2026-08-23T07:41:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}